Healthcare
Live Price
Offline$0.0011
+0.00% today
1Y Change
+266.67%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 254 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Primemd Inc. (PRMD) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 266.7% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 39.6% and ROIC 27.5%. Valuation is more restrained than many high-expectation growth names at P/E 0.0 and price/sales 0.0. Stock Foundry combines PRMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PRMD
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PRMD Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PRMD and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$39.1K
-25.7% YoY
FY Net Income
-$159.4K
-2.5% YoY
Free Cash Flow
-$161.1K
-18.6% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
100.0%
Net Margin
29.9%
Income statement
USD
| Metric | 2021 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Revenue | 11M | 68K | 49K | 53K | 39K |
| Gross Profit | 11M | 68K | 49K | 53K | 39K |
| Operating Income | 4M | -107K | -216K | -165K | -199K |
| EBITDA | 3M | -104K | -212K | -158K | -189K |
| Net Income | 3M | -101K | 195K | -156K | -159K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 416K | 550K | 751K | 938K |
| Total Assets | 15M | 1M | 1M | 1M | 1M |
| Total Liabilities | 8M | 124K | 5K | 12K | 17K |
| Shareholder Equity | 7M | 1M | 1M | 1M | 1M |
| Total Debt | 7M | 123K | 0 | 0 | 0 |
| Net Debt | 5M | -292K | -550K | -751K | -938K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
157K
-15.9% YoY
Capital Expenditures
4K
Free Cash Flow
161K
-18.6% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
39.6%
Net Margin
29.9%
ROE
73.3%
Debt / Equity
0.97x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.